Delivering%20Instructions_Cancer-01_edited.png

SOL Bio is the Global Leading Company
in Exosome-based Cancer Diagnostics

Exosomes for Cancer Diagnostics

  • When found early, cancer is often effectively treated or even cured. We aim to integrate early-stage cancer diagnosis into the nation-funded health examination, helping health professions to give accurate information to cure the disease effectively
     

  • SOL Bio is planning to carry out research and development of in vitro diagnostic products for immuno-isolation and analysis of exosomes, along with CDx (companion diagnostics) products and platform service businesses
     

  • SOL Bio has five types of unique technologies (Smart Operation Linkage; 'SOL') in the form of intellectual property or know-how that can meet unmet needs in the field of in vitro diagnostics, including companion diagnostics
     

  • These technologies are co-diagnosis platform technologies, which are expected to substantially contribute to the treatment of various acute and chronic diseases (cancer, inflammation, diabetes, etc.) in the future, resulting in significant corporate value growth

SOL BIO's VISION

Isolaion of Disease-specific Exosomes and Application of Exosome as a Biomarker

for Diagnosis and Treatment of Diseases

Exosome Marker Networking for Personalized Medicine (Exosome Biobank)